We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.8B
AUM Growth
-$14.9M
Cap. Flow
+$218M
Cap. Flow %
1.7%
Top 10 Hldgs %
47.35%
Holding
887
New
65
Increased
163
Reduced
583
Closed
74

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$37M
2
EIX icon
Edison International
EIX
+$36.3M
3
ETR icon
Entergy
ETR
+$35.8M
4
PKG icon
Packaging Corp of America
PKG
+$35.3M
5
NWL icon
Newell Brands
NWL
+$35.1M

Sector Composition

Rank Sector Weight
1 Energy 62.99%
2 Financials 8.19%
3 Healthcare 3.89%
4 Consumer Discretionary 3.19%
5 Technology 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
201
Merck
MRK
$324B
$2.81M 0.02%
32,375
-1,529
-5% -$126K
MA icon
202
Mastercard
MA
$477B
$2.79M 0.02%
9,342
-308
-3% -$86.8K
LLY icon
203
Eli Lilly
LLY
$1.07T
$2.77M 0.02%
21,109
-1,029
-5% -$119K
MINT icon
204
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$2.76M 0.02%
27,196
-500
-2% -$50.8K
ORTX
205
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.63M 0.02%
19,108
+192
+1% +$23.3K
MIC
206
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$2.58M 0.02%
60,283
-1,797
-3% -$74.2K
REGI
207
DELISTED
Renewable Energy Group, Inc.
REGI
$2.57M 0.02%
95,426
+18,854
+25% +$342K
CHRS icon
208
Coherus Oncology
CHRS
$217M
$2.54M 0.02%
+141,365
New +$2.61M
VGIT icon
209
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$2.46M 0.02%
37,341
-35
-0.1% -$2.32K
ENTA icon
210
Enanta Pharmaceuticals
ENTA
$372M
$2.46M 0.02%
39,744
+470
+1% +$29.1K
ALEC icon
211
Alector
ALEC
$164M
$2.39M 0.02%
+138,918
New +$2.36M
MDT icon
212
Medtronic
MDT
$107B
$2.39M 0.02%
21,031
-1,010
-5% -$111K
HDB icon
213
HDFC Bank
HDB
$119B
$2.34M 0.02%
73,880
+21,260
+40% +$647K
INTU icon
214
Intuit
INTU
$81.1B
$2.32M 0.02%
8,869
+190
+2% +$49.7K
PLUG icon
215
Plug Power
PLUG
$2.92B
$2.31M 0.02%
730,671
+224,852
+44% +$684K
RCKT icon
216
Rocket Pharmaceuticals
RCKT
$348M
$2.31M 0.02%
+101,466
New +$1.69M
INFY icon
217
Infosys
INFY
$45B
$2.26M 0.02%
218,608
+58,158
+36% +$585K
IBN icon
218
ICICI Bank
IBN
$106B
$2.22M 0.02%
146,923
+44,600
+44% +$605K
AMGN icon
219
Amgen
AMGN
$203B
$2.21M 0.02%
9,181
-372
-4% -$82K
AM icon
220
Antero Midstream
AM
$10.8B
$2.13M 0.02%
281,262
+63,844
+29% +$404K
DHC
221
Diversified Healthcare Trust
DHC
$2.26B
$2.12M 0.02%
251,498
+152,841
+155% +$1.29M
SVC
222
Service Properties Trust
SVC
$1.1B
$2.11M 0.02%
17,374
+9,403
+118% +$1.15M
GOSS icon
223
Gossamer Bio
GOSS
$66.5M
$2.08M 0.02%
133,059
+1,638
+1% +$33K
TMO icon
224
Thermo Fisher Scientific
TMO
$211B
$2.07M 0.02%
6,368
-255
-4% -$77.3K
EVA
225
DELISTED
Enviva Inc.
EVA
$2.02M 0.02%
54,172
+10,629
+24% +$361K

Similar funds

ALPS Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, ALPS Advisors held 887 positions worth $12.8B, down 0.12% from $12.8B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ALPS Advisors's Q4 2019 filing shows 65 new, 163 increased, 583 reduced and 74 closed positions. Its largest new stake was CenterPoint Energy: 1,338,870 shares worth $36.5M. The largest sale was Qualcomm, an estimated $37M.

By sector, the portfolio is most concentrated in Energy at 63% of assets, down from 65% a quarter earlier, followed by Financials and Healthcare.

  • ALPS Advisors's largest Q4 2019 buy was CenterPoint Energy: 1,338,870 shares worth $36.5M.
  • ALPS Advisors added most to PHILLIPS 66 PARTNERS LP in Q4 2019, an estimated $102M increase.
  • ALPS Advisors's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $37M.
  • ALPS Advisors fully exited Edison International in Q4 2019, selling an estimated $36.3M.
  • ALPS Advisors's ten largest holdings make up 47% of its $12.8B portfolio in Q4 2019.
  • ALPS Advisors opened 65 new positions and closed 74 in Q4 2019.
  • ALPS Advisors's portfolio value fell 0.12% quarter-over-quarter to $12.8B.

Based on ALPS Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.